Rankings
▼
Calendar
RCKT FY 2012 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$539M
FY 2012 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-2.88
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$486,000
Balance Sheet
Total Assets
$1M
Total Liabilities
$32M
Stockholders' Equity
-$31M
Cash & Equivalents
$1M
← FY 2013
All Quarters
